Navid Farzad

DexCare Board Observer and Partner, Frist Cressey Ventures

Navid Farzad, is a partner with Frist Cressey Ventures, a Nashville based venture capital firm focused on improving healthcare by partnering with entrepreneurs building transformative organizations.

Prior to FCV, Navid was a partner with Morgan Noble Healthcare Partners, a Washington, D.C. based private investment firm investing in companies determined to transform the delivery of healthcare.  In addition, Navid was Chief Strategy Officer of Continuum Health, a physician enablement company that drives better practice efficiency and population health outcomes for medical groups through technology-enabled solutions.

Navid serves on the boards of Audacious Inquiry, DexCare, Klara, Objective Health and Vim as a director or observer.  Prior to Morgan Noble, he was with Enhanced Healthcare Partners, a healthcare-focused private equity firm based in New York.  Previously, he held positions with Lehman Brothers in the health care investment banking division, Ernst & Young’s Transaction Advisory group, and Arthur Andersen’s health care practice.

Navid holds an MBA from the NYU Stern School of Business and a BA from Loyola University in Maryland.